Clinical Trial Update: Regenerative Stem Cell Therapy for Stroke in Europe [Phase 2, Phase 3]

View source ↗

Summary

A stem cell therapy trial for stroke in Europe has been withdrawn after Phase 2/3 enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Stroke | Phase 2, Phase 3 | Status: WITHDRAWN